Lars Fruergaard Jørgen
Lars Fruergaard Jørgen is the former CEO of Novo Nordisk, a leading Danish pharmaceutical company known for its groundbreaking weight-loss medications such as Ozempic and Wegovy. He stepped down in May 2023 amid a significant decline in the company's stock value, which had dropped over 50% in the previous year, due to increased competition and pressures on profit margins.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Italy:
Lars Fruergaard Jørgen announced his resignation as CEO of Novo Nordisk amid a significant drop in the company's stock value.
3